Difference between revisions of "WSI23-3-Case-1"

From MGH Learn Pathology
(Created page with "{{ServiceRequestCase |requisition=null |subject=MGH |intent=order |occurrenceDateTime=2023/01/09 00:00 |basedOn=WSI23-3 |priority=routine |code=faculty |orderDetail=case |auth...")
 
(Added status template)
 
(One intermediate revision by one other user not shown)
Line 49: Line 49:
 
|status=completed
 
|status=completed
 
|type=image
 
|type=image
|subject=Z0FBQUFBQmp1SEJlT1VvY0N4Y0QybVV4YjRSNnF2WHNQQzZCUVlIajBBNm1NOWM4OTdWTjdOa0dEckl2M0ZBa1lMMnZHOGJjdktMdnZMQ292Y3pHOFpfRklRMl8zS3F4VGxlS19idTRnRkNoWm1pT3lBWU12TUk9
+
|subject=Z0FBQUFBQmp1SEpXUHlTMXRvWDNYVUI3cGJHTUVxR0ZqQldpdGhnYU1CSjhjcXRlUXEzRnFsWjVPM0p2RjFQZkNOLXhZODBZNEFwZE1ZSnVnNF9MUDRxY2ZwVG5HbVBubkg1ZVRlVERrZWROamxpRlRZbFp4Vlk9
|reasonCode=Caldesmon
+
|reasonCode=Desmin
 
|view=show
 
|view=show
 
|modality=mrxs
 
|modality=mrxs
Line 59: Line 59:
 
|status=completed
 
|status=completed
 
|type=image
 
|type=image
|subject=Z0FBQUFBQmp1SEJUcUJxM09IeDRIVjVWZmZockdYMUFJbngxLXdGVjFua0hxLVg2Y29ab3dyLS0zRmxYX2lJeWlUa1NRcHJKLW03NEtOdlc2ZjZmazhQZDBnUHA3Z08zYzg3bWhHQW0xaTVtam9Iem5jNlYzTHc9
+
|subject=Z0FBQUFBQmp1SEpTRDNTWE1WOXNEbDBxbFVtSVVqV2JOTlB4cnJ3Ui11YWE3bzZzbVozbWtGR0pBUElvTGZXNFR3cWZXeUJPRU43cFNxN3RiWWdhQUdMa0tJYlZNSTFCeVBDS19Yb1hVR25yOEFCeFpfN0R3NDA9
|reasonCode=Desmin
+
|reasonCode=Caldesmon
 
|view=show
 
|view=show
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Aja51
 +
|authoredOn=January 06, 2023 06:56:35 PM
 
}}
 
}}

Latest revision as of 14:47, December 9, 2024

WSI23-3-Case-1
Leiomyosarcoma of left hip region
A. LEFT FEMUR DISTAL MORROW MARGIN:

Bone marrow with maturing trilineage hematopoiesis. There is no evidence of malignancy. B. LEFT PROXIMAL FEMUR EXCISION: Metastatic leiomyosarcoma (6.2 cm) (see note). Margins are negative for sarcoma (closest anterior and posterior soft tissue margins are 0.2 cm from sarcoma). Healing fracture site. Bone marrow with maturing trilineage hematopoiesis

Note: By immunohistochemistry the tumor is diffusely positive for muscle actin, SMA, caldesmon and desmin.
January 9, 2023 12:00:00 AM